Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 90 | ECE2023 | Next issue

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

Card image cap
ECE 2023 will be held in Istanbul, Turkey from 13-16 May 2023. Istanbul is known for its rich culture, historical sites and dynamic nightlife, and we are excited to come together in this city, and look forward to meeting old friends, making new ones, and sharing science, collaborations and ideas.

Symposia

Aberrant/illicit expression of receptors in adrenal lesions

ea0090s7.1 | Aberrant/illicit expression of receptors in adrenal lesions | ECE2023

GnRH in primary aldosteronism

Lacroix Andre

The mechanisms regulating aldosterone secretion in primary aldosteronism (PA) independently from the renin-angiotensin axis include diverse genetic and molecular mechanisms. One mechanism results from the activation of aberrantly expressed GPCR which are diverse and highly prevalent in adrenal tissues of patients with PA, either from aldosteronoma or bilateral adrenal hyperplasia. The levels of expression of GPCR vary greatly between different PA tissues particularly for ACTH ...

ea0090s7.3 | Aberrant/illicit expression of receptors in adrenal lesions | ECE2023

LHCG Receptor in pheochromocytoma

Lopez Antoine-Guy , Duparc Celine , Renouf Sylvie , Sabourin Jean-Christophe , Buffet Alexandre , Gimenez-Roqueplo Anne-Paule , Dubessy Christophe , Louiset Estelle , Lefebvre Herve

Pheochromocytomas/paragangliomas (PPGL) are catecholamine-producing neuroendocrine tumors that account for less than 1% of all hypertension cases. Despite their rarity, these tumors must be early detected and treated to prevent potentially life-threatening adrenergic crises. Unfortunately, PPGL are frequently unrecognized during pregnancy, leading to a high risk of either maternal or fetal complications. In return, pregnancy can trigger catecholamine secretory discharges in pa...